RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 51 filers reported holding RECRO PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,000 | -8.3% | 1,311 | 0.0% | 0.00% | – |
| Q3 2016 | $12,000 | +33.3% | 1,311 | +22.2% | 0.00% | – |
| Q2 2016 | $9,000 | +80.0% | 1,073 | +29.9% | 0.00% | – |
| Q1 2016 | $5,000 | -28.6% | 826 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | -22.2% | 826 | +10.6% | 0.00% | – |
| Q3 2015 | $9,000 | -10.0% | 747 | 0.0% | 0.00% | – |
| Q2 2015 | $10,000 | +66.7% | 747 | +11.2% | 0.00% | – |
| Q1 2015 | $6,000 | +200.0% | 672 | -14.5% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 786 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -66.7% | 786 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | – | 786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |